相关实验视频

Updated: Jun 29, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

根除巨型瘤疾病:有效的放射性免疫治疗的先决条件?

Eric Deutsch^1,2,3, Antonin Levy^1,2,3

¹Department of Radiation Oncology, Gustave Roussy, Villejuif, France.

Journal of the National Cancer Institute

|March 28, 2024

概括

将放射疗法与免疫疗法结合起来是有前途的,尤其是在消除瘤后. 然而,结果各不相同,整体瘤负担可能会影响晚期癌症患者的放射性免疫疗法的有效性.

科学领域:

辐射瘤学和医学免疫学
癌症免疫疗法研究研究

背景情况:

辐射疗法可以触发腹膜效应,影响抗瘤免疫和免疫抑制.
临床前和早期临床研究表明,放射治疗和免疫刺激剂之间存在协同作用.
放射性免疫疗法在晚期癌症环境中产生了不同的结果.

研究的目的:

审查放射性免疫疗法的随机试验结果.
探索瘤负担对放射性免疫治疗疗效的影响.
分析什么时候免疫疗法与放射治疗结合最有效.

主要方法:

审查现有的随机临床试验数据.
基于瘤负担的放射性免疫治疗结果的分析.
讨论将放射治疗与免疫治疗联系起来的临床证据.

主要成果:

大多数在晚期瘤中进行放射性免疫治疗的随机试验显示出令人失望的结果.
当免疫疗法随着治愈意图的辐射疗法随着严重疾病的消除而进行时,观察到令人鼓舞的结果.
整体瘤负担似乎是放射性免疫治疗疗效的关键因素.

结论:

与放射治疗相比,免疫治疗的时间和背景至关重要.
放射性免疫疗法在通过辐射显著减少瘤后使用时可能更有效.
根据瘤负担,对优化放射性免疫治疗的进一步研究是有必要的.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.